PVG.L Regulatory News (PVG)

24 Apr 2008 16:57

Ark Therapeutics Group PLC24 April 2008 Ark Therapeutics Group plc Results of Annual General Meeting London, UK, 24 April 2008: At the Annual General Meeting of Ark TherapeuticsGroup plc (LSE: AKT) held today all resolutions were duly passed with theexception of resolution 11. Resolution 11 was to empower the Directors to allotsecurities pursuant to section 95 of the Company's Act 1985 in respect of awarrant instrument of the Company dated 13 December 2006. A summary of the proxy voting will be published in the Investor Relationssection of the Company's website at www.arktherapeutics.com. Copies of the approved resolutions will be submitted to the UK Listing Authorityand will shortly be available for inspection at the UK Listing Authority'sDocument Viewing Facility, which is situated at: Financial Services Authority 25 The North Colonnade Canary Wharf London E14 5HS Tel: +44 (0) 20 7676 1000 Enquiries: Ark Therapeutics Group plcMartyn Williams, Company Secretary +44 (0)20 7388 7722 Financial Dynamics +44 (0)20 7831 3113David YatesSusan Quigley This information is provided by RNS The company news service from the London Stock Exchange